Company profile for Supernus Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Over the last 30 years, we have built an extensive expertise in product development. Initially, we were a stand-alone development organization, then a U.S. subsidiary of Shire plc and, in late 2005, we became Supernus Pharmaceuticals, Inc. We market our products within the United Sta...
We are a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Over the last 30 years, we have built an extensive expertise in product development. Initially, we were a stand-alone development organization, then a U.S. subsidiary of Shire plc and, in late 2005, we became Supernus Pharmaceuticals, Inc. We market our products within the United States through our own specialty sales forces. We also seek strategic collaborations with other pharmaceutical companies to license our products outside the United States.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1550 East Gude Drive Rockville, MD 20850
Telephone
Telephone
(301) 838-2500
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/21/3193017/19871/en/Supernus-Pharmaceuticals-to-Participate-in-the-Piper-Sandler-37th-Annual-Healthcare-Conference.html

GLOBENEWSWIRE
21 Nov 2025

https://www.globenewswire.com/news-release/2025/11/12/3186793/19871/en/Supernus-to-Participate-in-the-2025-Jefferies-Global-Healthcare-Conference-in-London.html

GLOBENEWSWIRE
12 Nov 2025

https://www.fiercepharma.com/manufacturing/supernus-pauses-new-patient-starts-parkinsons-pump-onapgo-citing-higher-expected

FIERCE PHARMA
05 Nov 2025

https://www.globenewswire.com/news-release/2025/11/04/3180807/19871/en/Supernus-Announces-Third-Quarter-2025-Financial-Results.html

GLOBENEWSWIRE
04 Nov 2025

https://www.globenewswire.com/news-release/2025/10/21/3170691/19871/en/Supernus-Pharmaceuticals-to-Announce-Third-Quarter-2025-Financial-Results-and-Host-Conference-Call-on-November-4-2025.html

GLOBENEWSWIRE
21 Oct 2025

https://www.globenewswire.com/news-release/2025/08/27/3140385/19871/en/Supernus-Pharmaceuticals-to-Participate-in-September-Investor-Conferences.html

GLOBENEWSWIRE
27 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty